Chiara Gentilini

1.2k total citations
24 papers, 932 citations indexed

About

Chiara Gentilini is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Chiara Gentilini has authored 24 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 16 papers in Immunology and 6 papers in Oncology. Recurrent topics in Chiara Gentilini's work include Hematopoietic Stem Cell Transplantation (14 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (9 papers). Chiara Gentilini is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (9 papers). Chiara Gentilini collaborates with scholars based in Germany, United States and Netherlands. Chiara Gentilini's co-authors include Volker Lennerz, Catherine Wölfel, Thomas Wölfel, Martina Fatho, Alexander Lifke, Christoph Huber, Roy A. Frye, Lars Fischer, L. Uharek and Olaf Penack and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and European Journal of Immunology.

In The Last Decade

Chiara Gentilini

24 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Gentilini Germany 14 605 396 252 177 125 24 932
Cornelis A.M. van Bergen Netherlands 20 949 1.6× 480 1.2× 622 2.5× 232 1.3× 92 0.7× 53 1.3k
Antoinette Chillemi United States 11 429 0.7× 206 0.5× 358 1.4× 135 0.8× 93 0.7× 12 718
Thai M. Cao United States 17 319 0.5× 296 0.7× 379 1.5× 164 0.9× 70 0.6× 48 866
Anne Marie Asemissen Germany 15 764 1.3× 493 1.2× 179 0.7× 408 2.3× 63 0.5× 31 1.1k
Jacopo Mariotti Italy 20 667 1.1× 410 1.0× 562 2.2× 158 0.9× 111 0.9× 56 1.2k
K Cochran United States 11 942 1.6× 376 0.9× 363 1.4× 174 1.0× 83 0.7× 15 1.2k
J Klarnet United States 13 491 0.8× 434 1.1× 361 1.4× 120 0.7× 53 0.4× 16 884
J Daley United States 8 627 1.0× 254 0.6× 149 0.6× 140 0.8× 73 0.6× 9 799
Matthias Zeis Germany 16 634 1.0× 314 0.8× 368 1.5× 229 1.3× 53 0.4× 42 931
R E Gress United States 12 434 0.7× 185 0.5× 245 1.0× 197 1.1× 64 0.5× 16 748

Countries citing papers authored by Chiara Gentilini

Since Specialization
Citations

This map shows the geographic impact of Chiara Gentilini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Gentilini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Gentilini more than expected).

Fields of papers citing papers by Chiara Gentilini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Gentilini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Gentilini. The network helps show where Chiara Gentilini may publish in the future.

Co-authorship network of co-authors of Chiara Gentilini

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Gentilini. A scholar is included among the top collaborators of Chiara Gentilini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Gentilini. Chiara Gentilini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uharek, Lutz, Birte Friedrichs, Axel Nogai, et al.. (2010). Successful Treatment of High-Risk and Refractory Acute Myeloid Leukemia with haploidentical Stem Cell Transplantation Plus NK cell therapy. Blood. 116(21). 2370–2370. 5 indexed citations
2.
Al‐Ali, Haifa Kathrin, Christina Franke, Michael Hudecek, et al.. (2009). Mesenchymal Stem Cells Remain Host-Derived Independent of the Source of the Stem-Cell Graft and Conditioning Regimen Used. Transplantation. 87(2). 217–221. 44 indexed citations
3.
Gentilini, Chiara, Thoralf Lange, Catherine Wölfel, et al.. (2008). Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia. Leukemia. 22(8). 1542–1550. 16 indexed citations
4.
5.
Ganepola, Susanne, Chiara Gentilini, Thoralf Lange, et al.. (2007). Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation. Bone Marrow Transplantation. 39(5). 293–299. 71 indexed citations
6.
Penack, Olaf, Lars Fischer, Andrea Stroux, et al.. (2007). Serotherapy with thymoglobulin and alemtuzumab differentially influences frequency and function of natural killer cells after allogeneic stem cell transplantation. Bone Marrow Transplantation. 41(4). 377–383. 18 indexed citations
7.
Penack, Olaf, Lars Fischer, Chiara Gentilini, et al.. (2007). The type of ATG matters — Natural killer cells are influenced differentially by Thymoglobulin, Lymphoglobulin and ATG-Fresenius. Transplant Immunology. 18(2). 85–87. 30 indexed citations
8.
9.
Wolff, Daniel, Stefan Wilhelm, J. Hahn, et al.. (2006). Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease. Bone Marrow Transplantation. 38(6). 445–451. 42 indexed citations
10.
Fischer, Lars, Olaf Penack, Chiara Gentilini, et al.. (2006). The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells. Experimental Hematology. 34(6). 753–759. 62 indexed citations
11.
Gentilini, Chiara, et al.. (2006). Vaccination with the WT-1 126-134 Peptide in Patients with Acute Myeloid Leukemia after Allogenic Stem Cell Transplantation.. Blood. 108(11). 3683–3683. 1 indexed citations
12.
Fietz, Thomas, L. Uharek, Chiara Gentilini, et al.. (2005). Allogeneic hematopoietic cell transplantation following conditioning with90Y-ibritumomab-tiuxetan. Leukemia & lymphoma. 47(1). 59–63. 23 indexed citations
13.
Penack, Olaf, Chiara Gentilini, Lars Fischer, et al.. (2005). CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets. Leukemia. 19(5). 835–840. 112 indexed citations
14.
Meyer, Ralf G., Cedrik M. Britten, Abdo Konur, et al.. (2005). Preemptive Transfer of GMP-Grade CD8-Depleted Donor Lymphocytes after T-Cell Depleted Reduced-Intensity Transplantation.. Blood. 106(11). 297–297. 6 indexed citations
15.
Niederwieser, Dietger, Chiara Gentilini, Ute Hegenbart, et al.. (2005). Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemias. Critical Reviews in Oncology/Hematology. 56(2). 275–281. 5 indexed citations
16.
Lennerz, Volker, Martina Fatho, Chiara Gentilini, et al.. (2005). The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proceedings of the National Academy of Sciences. 102(44). 16013–16018. 348 indexed citations
17.
18.
Gentilini, Chiara, Susanne Ganepola, Carmen Scheibenbogen, et al.. (2005). WT1-Specific T Cell Responses Are Frequent after Allogeneic Stem Cell Transplantation for Acute and Chronic Myeloid Leukemia.. Blood. 106(11). 598–598. 1 indexed citations
19.
Lange, Thoralf, Michael W. Deininger, R. Brand, et al.. (2004). BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning. Leukemia. 18(9). 1468–1475. 19 indexed citations
20.
Niederwieser, Dietger, Chiara Gentilini, Ute Hegenbart, et al.. (2004). Transmission of donor illness by stem cell transplantation: should screening be different in older donors?. Bone Marrow Transplantation. 34(8). 657–665. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cornelis A.M. van Bergen Breakdown of academic impact, for papers by Antoinette Chillemi Breakdown of academic impact, for papers by Thai M. Cao Breakdown of academic impact, for papers by Anne Marie Asemissen Breakdown of academic impact, for papers by Jacopo Mariotti Breakdown of academic impact, for papers by K Cochran Breakdown of academic impact, for papers by J Klarnet Breakdown of academic impact, for papers by J Daley Breakdown of academic impact, for papers by Matthias Zeis Breakdown of academic impact, for papers by R E Gress
Rankless by CCL
2026